Ilaria Ponziani

Dr. Ilaria Ponziani

Azienda Ospedaliera Universitaria Careggi, Florence, Tuscany, Italy
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2022 in Children
Verified
Journal Article
Open access
PDF file
LPLucia Pasquini
Lucia Pasquini
IPIlaria Ponziani
Ilaria Ponziani
MPMarta Pallottini
Marta Pallottini
GMGiulia Masini
Giulia Masini
Viola SeravalliViola Seravalli
Viola Seravalli
MARIAROSARIA DI TOMMASOMARIAROSARIA DI TOMMASO
MARIAROSARIA DI TOMMASO
Background: Idiopathic polyhydramnios is a controversial clinical condition, as data on perinatal outcomes are conflicting and vary depending on the severity of the condition. The aim of the present study was to compare obstetric and neonatal outcomes between pregnant women with mild idiopathic polyhydramnios and a control population. Methods: A retrospective cohort study was performed at a single university hospital comparing the obstetrics and neonatal outcomes of pregnancies with mild idiopathic polyhydramnios (n = 109) and control pregnancies (n = 2550). Results: Cesarean section (CS) was significantly increased in the group with polyhydramnios compared to controls (46% vs. 32%, respectively, p = 0.047) due to a higher rate of emergency CS in the polyhydramnios group (p = 0.041) because of abnormal cardiotocography (7.3% vs. 2.9%; p = 0.018) or labor dystocia (8.2% vs. 2.9%; p = 0.006). No statistically significant difference was found in the Apgar score, in the rate of neonatal hypoxia, or in the incidence of macrosomia between groups. In four cases, additional diagnoses of anomalies were made after birth, with a rate of 3.2%, which is comparable to the general population. Conclusion: Besides an increased risk of CS, patients with mild idiopathic polyhydramnios should be reassured regarding maternal and feto-neonatal outcomes. The management of pregnancies with stable mild idiopathic polyhydramnios should not differ from uncomplicated pregnancies, except for the need for increased labor surveillance.

2 May 2023 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
LPLucia Pasquini
Lucia Pasquini
IPIlaria Ponziani
Ilaria Ponziani
ESElisa Spataro
Elisa Spataro
GMGiulia Masini
Giulia Masini
EBEleonora Biancareddu
Eleonora Biancareddu
FPFelice Petraglia
Felice Petraglia

22 November 2018 in Fetal Diagnosis and Therapy
Verified
Journal Article
Closed access
PDF file
LPLucia Pasquini
Lucia Pasquini
IPIlaria Ponziani
Ilaria Ponziani
EPEnrico Periti
Enrico Periti
LMLaura Marchi
Laura Marchi
CLCarlo Luchi
Carlo Luchi
NPNicola Persico
Nicola Persico
Objective: To examine the distribution of risks for fetal trisomies after first-trimester combined screening in twins and to investigate different strategies for clinical implementation of cell-free DNA (cfDNA) testing. Methods: We retrospectively analyzed all twin pregnancies undergoing first-trimester combined screening over a 10 years’ period. The population was stratified according to various risk cut-offs, and we examined different screening strategies for implementation of cfDNA testing in terms of impact on invasive testing rate, cfDNA test failure rate, and economic costs. Results: We included 572 twin pregnancies: 480 (83.92%) dichorionic and 92 (16.08%) monochorionic. Performing a first-line combined screening and offering cfDNA testing to the group with a risk between 1 in 10 and 1 in 1,000, would lead to an invasive testing rate of 2.45%, and cfDNA testing would be performed in 22.20% of the population. This strategy would be cost-neutral compared to universal combined screening alone. Conclusions: First-trimester combined screening results can be used to stratify twin pregnancies into different risk categories and select those that could be offered cfDNA testing. A contingent screening strategy would substantially decrease the need for invasive testing in twins and it would be cost-neutral compared to combined testing alone.

15 September 2026 in Journal of Medical Screening
Verified
Journal Article
Closed access
MSMichele Santoro
Michele Santoro
IPIlaria Ponziani
Ilaria Ponziani
LPLaura Perna
Laura Perna
ACAlessio Coi
Alessio Coi
MAMaria Valentina Abate
Maria Valentina Abate
LPLucia Pasquini
Lucia Pasquini
Objective: To evaluate the impact of screening policies in Tuscany on the detection of trisomy 13 and trisomy 18 (T13/T18) with respect to time of diagnosis. A secondary aim was to evaluate the prevalence of these aneuploidies and to report the associated malformations. Methods: Data were extracted from the population-based Registry of Congenital Anomalies of Tuscany. All confirmed cases of T13/T18 among live births, stillbirths, miscarriages and terminations of pregnancy were included over a 30-year period (1994–2023). The prevalence for both aneuploidies was calculated overall and by age group (<35 years old; ≥ 35 years old). For prenatally diagnosed cases, median gestational age at diagnosis was calculated. The frequencies of the most common associated abnormalities were also calculated. Results: About 529 fetuses were diagnosed with T13/T18, respectively 133 (25.1%) and 396 (74.9%). The prevalence among 10,000 births was 1.67 (95% CI 1.40–1.98) for T13 and 4.98 (95% CI 4.45–5.49) for T18. Prenatal detection rate for T13 increased from 88.2% (95% CI 72.5–96.7) to 100% (95% CI 88.1–100.0). For T18, it increased from 87.5% (95% CI 79.2–93.4) to 100% (95% CI 95.0–100.0). Median gestational age at discovery gradually decreased for both trisomies through the study period, from 17 to 12 weeks. The most common anomalies in T13 were nervous system anomalies (27.8%) and congenital heart defects (9.8%). T18-associated anomalies included congenital heart defects (11.9%) and nervous system anomalies (10.1%). Conclusion: The implementation of screening policies led to an improvement in the rate of detection of T13/18 and a decrease in the median gestational age at diagnosis.

1 September 2023 in Minerva Obstetrics and Gynecology
Verified
Journal Article
Closed access
IPIlaria Ponziani
Ilaria Ponziani
MPMarta Pallottini
Marta Pallottini
GMGiulia Masini
Giulia Masini
CFChiara Franchi
Chiara Franchi
SBSilvia Balli
Silvia Balli
LPLucia Pasquini
Lucia Pasquini
Article: Invasive prenatal diagnosis in the era of cell-free fetal DNA: experience at a single center - Minerva Obstetrics and Gynecology 2023 October;75(5):393-8 - Minerva Medica - Journals